APA (7th ed.) Citation

Y, Q., Z, W., H, Z., M, K., R, D., & J, Z. (2017). Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Qu, Wang Z, Zhou H, Kang M, Dong R, and Zhao J. Oligosaccharide Nanomedicine of Alginate Sodium Improves Therapeutic Results of Posterior Lumbar Interbody Fusion with Cages for Degenerative Lumbar Disease in Osteoporosis Patients by Downregulating Serum MiR-155. Dove Medical Press, 2017.

MLA (8th ed.) Citation

Y, Qu, et al. Oligosaccharide Nanomedicine of Alginate Sodium Improves Therapeutic Results of Posterior Lumbar Interbody Fusion with Cages for Degenerative Lumbar Disease in Osteoporosis Patients by Downregulating Serum MiR-155. Dove Medical Press, 2017.